Replay available

Evolent Health, Inc. (EVH) Q3 2025 Earnings Call

Evolent Health, Inc. (NYSE: EVH) Q3 2025 earnings conference call, held 2025-11-06. Replay captured from the company's public earnings webcast.

Thu, November 6, 2025 at 5:00 PMendedReplay
Evolent Health, Inc. (EVH) Q3 2025 Earnings Call

Investor webinar replay

Latest press releases

Companies on this event

Featured Presenters

Seth Blackley

Chief Executive Officer

John Johnson

Chief Financial Officer

Kevin Caliendo

Analyst, UBS

Daniel Grosslight

Analyst, Citi

John Stansel

Analyst, J.P. Morgan

Charles Rhee

Analyst, TD Cowen

Eduardo Ranon

Analyst, Truist Securities

Jeff Garrow

Analyst, Stephens

Jessica Tassin

Analyst, Piper Sandler

David Larson

Analyst, BTIG

Matthew Shea

Analyst, Needham

Matthew Gilmore

Analyst, KeyBank

Replay transcript excerpt

Welcome to the Evelyn Earnings Conference Call for the third quarter ended September 30, 2025. As a reminder, this conference call is being recorded. Your hosts for the call today from Evelyn are Seth Blackley, Chief Executive Officer, and John Johnson, Chief Financial Officer. This call will be archived and available later this evening and for the next week via the webcast on the company's website in the section titled Investor Relations. This conference call will contain forward-looking statements under the U.S. federal laws. These statements are subject to risks and uncertainties that could cause actual results to differ materially from historical experience or present expectations. A description of some of the risks and uncertainties can be found in the company's reports that are filed with the Securities and Exchange Commission, including cautionary statements included in our current and periodic filings. For additional information on the company's results and outlook, please refer to our third quarter press release issued earlier today. Finally, as a reminder, reconciliations of non-GAAP measures discussed during today's call to the most direct comparable GAAP measures are available in the summary presentation available in the investor relations section of our website or in the company's press release issued today and posted on the investor relations website, ir.gov. Evalent.com, and the Form 8K filed by the company with the SEC earlier today. In addition to reconciliations, we provide details on the numbers and operating metrics for the quarter in both our press release and supplemental investor presentation. And now, I will turn the call over to Evalent's CEO, Seth Blackley. Please go ahead. Good evening, and thanks for joining the call. On the call this even...

More from Evolent Health, Inc